CABENUVA
First approved long-acting injectable for HIV by Bob Kronemyer The first injectable and complete regimen for HIV-infected adults was approved in January by the Food and Drug Administration (FDA). Cabenuva (ViiV Healthcare and Janssen Pharmaceutica) is a combination of cabotegravir, an HIV integrase strand transfer inhibitor (INSTI), and rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), […]
Current Knowledge in Pediatric Psoriasis
Dr. Amy Paller discusses the knowns and unknowns of the disease process, risk factors, and therapies for pediatric psoriasis. Amy Paller, MD, is Professor and Chair of Dermatology at Northwestern, Chicago, Ill., and Professor of Pediatrics at the Robert H. Lurie Children’s Hospital of Chicago. “There’s a huge gap in knowledge about pediatric psoriasis because pretty […]